FDG PET of Infection and Inflammation

Published Online:https://doi.org/10.1148/rg.255045122

Nuclear medicine plays an important role in the evaluation of infection and inflammation. Fluorine 18 fluorodeoxyglucose (FDG) is a readily available radiotracer that offers rapid, exquisitely sensitive high-resolution tomography. In patients with acquired immunodeficiency syndrome, FDG positron emission tomography (PET) accurately helps localize foci of infection and is particularly useful for differentiating central nervous system lymphoma from toxoplasmosis. FDG PET can also help localize the source of fever of undetermined origin (FUO), thereby guiding additional testing. In the musculoskeletal system, FDG PET accurately helps diagnose spinal osteomyelitis, and in inflammatory conditions such as sarcoidosis and vasculitis, it appears to be useful for defining the extent of disease and monitoring response to treatment. FDG PET may be of limited usefulness in postoperative patients and in patients with a failed joint prosthesis or a tumor. Nevertheless, this relatively new imaging technique promises to be helpful in the diagnosis of infection and inflammation. FDG PET will likely assume increasing importance in assessing FUO, spinal osteomyelitis, vasculitis, and sarcoidosis and may even become the radionuclide imaging procedure of choice in the evaluation of some or all of these pathologic conditions.

© RSNA, 2005


  • 1 BellGI, Burant CF, Takeda J, Gould GW. Structure and function of mammalian facilitative sugar transporters. J Biol Chem1993; 268: 19161–19164. Crossref, MedlineGoogle Scholar
  • 2 PauwelsEK, Ribeiro MJ, Stoot JH, McCready VR, Bourguignon M, Maziere B. FDG accumulation and tumor biology. Nucl Med Biol1998; 25: 317–322. Crossref, MedlineGoogle Scholar
  • 3 ZhuangH, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med2002; 32: 47–59. Crossref, MedlineGoogle Scholar
  • 4 MochizukiT, Tsukamoto E, Kuge Y, et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med2001; 42: 1551–1555. MedlineGoogle Scholar
  • 5 KubotaR, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med1992; 33: 1972–1980. MedlineGoogle Scholar
  • 6 PaikJY, Lee KH, Choe YS, Choi Y, Kim BT. Augmented 18F-FDG uptake in activated monocytes occurs during the priming process and involves tyrosine kinases and protein kinase C. J Nucl Med2004; 45: 124–128. MedlineGoogle Scholar
  • 7 CookGJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med1996; 26: 308–314. Crossref, MedlineGoogle Scholar
  • 8 ShrevePD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. RadioGraphics1999; 19: 61–77. LinkGoogle Scholar
  • 9 NakaharaT, Fujii H, Ide M, et al. FDG uptake in the morphologically normal thymus: comparison of FDG positron emission tomography and CT. Br J Radiol2001; 74: 821–824. Crossref, MedlineGoogle Scholar
  • 10 RiniJN, Leonidas JC, Tomas MB, Chen B, Karayalcin G, Palestro CJ. 18F-FDG uptake in the anterior mediastinum: physiologic thymic uptake or disease? Clin Positron Imaging2000; 3: 115–125. Crossref, MedlineGoogle Scholar
  • 11 LoveC, Parithivel K, Bhargava KK, Pugliese PV, Palestro CJ. Splenic 18F-FDG uptake in patients with infection (abstr). Clin Nucl Med2005; 30: 375. Google Scholar
  • 12 YeungHW, Grewal RK, Gonen M, Schoder H, Larson SM. Patterns of 18F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. J Nucl Med2003; 44: 1789–1796. MedlineGoogle Scholar
  • 13 O’DohertyMJ, Barrington SF, Campbell M, Lowe J, Bradbeer CS. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med1997; 38: 1575–1583. MedlineGoogle Scholar
  • 14 HoffmanJM, Waskin HA, Schifter T, et al. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med1993; 34: 567–575. MedlineGoogle Scholar
  • 15 LoveC, Palestro CJ. Radionuclide imaging of infection. J Nucl Med Technol2004; 32: 47–57. MedlineGoogle Scholar
  • 16 BlockmansD, Knockaert D, Maes A, et al. Clinical value of [18 F]fluorodeoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis2001; 32: 191–196. Crossref, MedlineGoogle Scholar
  • 17 MellerJ, Altenvoerde G, Munzel U, et al. Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med2000; 27: 1617–1625. Crossref, MedlineGoogle Scholar
  • 18 Bleeker-RoversCP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging2004; 31: 29–37. Crossref, MedlineGoogle Scholar
  • 19 LorenzenJ, Buchert R, Bohuslavizki KH. Value of FDG PET in patients with fever of unknown origin. Nucl Med Commun2001; 22: 779–783. Crossref, MedlineGoogle Scholar
  • 20 YenRF, Chen YC, Wu YW, Pan MH, Chang SC. Using 18-fluoro-2-deoxyglucose positron emission tomography in detecting infectious endocarditis/endoarteritis: a preliminary report. Acad Radiol2004; 11: 316–321. Crossref, MedlineGoogle Scholar
  • 21 PalestroCJ, Love C, Tronco GG, Tomas MB. Role of radionuclide imaging in the diagnosis of postoperative infection. RadioGraphics2000; 20: 1649–1660. LinkGoogle Scholar
  • 22 MellerJ, Sahlmann CO, Lehmann K, et al. F-18-FDG hybrid camera PET in patients with postoperative fever. Nuklearmedizin2002; 41: 22–29. Crossref, MedlineGoogle Scholar
  • 23 LoveC, Pugliese PV, Palestro CJ. 18F-FDG imaging of infection (abstr). J Nucl Med2003; 45(suppl): 340. Google Scholar
  • 24 KjaerA, Lebech AM, Eigtved A, Hojgaard L. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging2004; 31: 622–626. Crossref, MedlineGoogle Scholar
  • 25 SchauweckerDS. The scintigraphic diagnosis of osteomyelitis. AJR Am J Roentgenol1992; 158: 9–18. Crossref, MedlineGoogle Scholar
  • 26 PalestroCJ, Torres MA. Radionuclide imaging in orthopedic infections. Semin Nucl Med1997; 27: 334–345. Crossref, MedlineGoogle Scholar
  • 27 GuhlmannA, Brecht-Krauss D, Suger G, et al. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology1998; 206: 749–754. LinkGoogle Scholar
  • 28 ZasadnyKR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-d-glucose: variations with body weight and a method for correction. Radiology1993; 189: 847–850. LinkGoogle Scholar
  • 29 SugawaraY, Braun DK, Kison PV, Russo JE, Zasadny KR, Wahl RL. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med1998; 25: 1238–1243. Crossref, MedlineGoogle Scholar
  • 30 De WinterF, Van de Wiele C, Vogelaers D, De Smet K, Verdonk R, Dierckx RA. Fluorine-18 fluorodeoxyglucose-positron emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am2001; 83-A: 651–660. MedlineGoogle Scholar
  • 31 KälickeT, Schmitz A, Risse JH, et al. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med2000; 27: 524–528. Crossref, MedlineGoogle Scholar
  • 32 MeyerM, Gast T, Raja S, Hubner K. Increased F-18 FDG accumulation in an acute fracture. Clin Nucl Med1994; 19: 13–14. Crossref, MedlineGoogle Scholar
  • 33 ZhuangH, Sam JW, Chacko TK, et al. Rapid normalization of osseous FDG uptake following traumatic or surgical fractures. Eur J Nucl Med Mol Imaging2003; 30: 1096–1103. Crossref, MedlineGoogle Scholar
  • 34 HenryG, Garner WL. Inflammatory mediators in wound healing. Surg Clin North Am2003; 83: 483–507. Crossref, MedlineGoogle Scholar
  • 35 LoveC, Marwin SE, Tomas MB, et al. Diagnosing infection in the failed joint replacement: a comparison of coincidence detection 18F-FDG and 111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging. J Nucl Med2004; 45: 1864–1871. MedlineGoogle Scholar
  • 36 National Institutes of Health. Deep infections of total joint replacements. Dec 1999; PA-00–014. Google Scholar
  • 37 LoveC, Tomas MB, Marwin SE, Pugliese PV, Palestro CJ. Role of nuclear medicine in diagnosis of the infected joint replacement. RadioGraphics2001; 21: 1229–1238. LinkGoogle Scholar
  • 38 SeaboldJE, Nepola JV. Imaging techniques for evaluation of postoperative orthopedic infections. Q J Nucl Med1999; 43: 21–28. MedlineGoogle Scholar
  • 39 ZhuangH, Duarte PS, Pourdehnad M, et al. The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants. J Nucl Med2001; 42: 44–48. MedlineGoogle Scholar
  • 40 MantheyN, Reinhard P, Moog F, Knesewitsch P, Hahn K, Tatsch K. The use of [18F] fluorodeoxyglucose positron emission tomography to differentiate between synovitis, loosening and infection of hip and knee prostheses. Nucl Med Commun2002; 23: 645–653. Crossref, MedlineGoogle Scholar
  • 41 Van AckerF, Nuyts J, Maes A, et al. FDG-PET, 99mTc-HMPAO white blood cell SPET and bone scintigraphy in the evaluation of painful total knee arthroplasties. Eur J Nucl Med2001; 28: 1496–1504. Crossref, MedlineGoogle Scholar
  • 42 VanquickenborneB, Maes A, Nuyts J, et al. The value of (18)FDG-PET for the detection of infected hip prosthesis. Eur J Nucl Med Mol Imaging2003; 30: 705–715. Crossref, MedlineGoogle Scholar
  • 43 StumpeKD, Notzli HP, Zanetti M, et al. FDG PET for differentiation of infection and aseptic loosening in total hip replacements: comparison with conventional radiography and three-phase bone scintigraphy. Radiology2004; 231: 333–341. LinkGoogle Scholar
  • 44 ModicMT, Feiglin DH, Piraino DW, et al. Vertebral osteomyelitis: assessment using MR. Radiology1985; 157: 157–166. LinkGoogle Scholar
  • 45 LoveC, Patel M, Lonner BS, Tomas MB, Palestro CJ. Diagnosing spinal osteomyelitis: a comparison of bone and Ga-67 scintigraphy and magnetic resonance imaging. Clin Nucl Med2000; 25: 963–977. Crossref, MedlineGoogle Scholar
  • 46 GratzS, Dörner J, Fischer U, et al. 18F-FDG hybrid PET in patients with suspected spondylitis. Eur J Nucl Med Mol Imaging2002; 29: 516–524. Crossref, MedlineGoogle Scholar
  • 47 StumpeKD, Zanetti M, Weishaupt D, Hodler J, Boos N, Von Schulthess GK. FDG positron emission tomography for differentiation of degenerative and infectious endplate abnormalities in the lumbar spine detected on MR imaging. AJR Am J Roentgenol2002; 179: 1151–1157. Crossref, MedlineGoogle Scholar
  • 48 LoveC, Palestro CJ. 18F-FDG and 67Ga-SPECT imaging in suspected vertebral osteomyelitis: an intraindividual comparison (abstr). J Nucl Med2003; 45(suppl): 148. Google Scholar
  • 49 Prevalence of diabetes. In: National Diabetes Statistics, National Diabetes Information Clearing-house. National Institutes of Health Publication Number 03–3892, May 2003. Google Scholar
  • 50 PalestroCJ, Tomas MB. Scintigraphic evaluation of the diabetic foot. In: Freeman LM, ed. Nuclear Medicine Annual 2000. Philadelphia, Pa: Lippincott Williams & Wilkins, 2000; 143–172. Google Scholar
  • 51 PalestroCJ, Mehta HH, Patel M, et al. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. J Nucl Med1998; 39: 346–350. MedlineGoogle Scholar
  • 52 BrudinLH, Valind SO, Rhodes CG, et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med1994; 21: 297–305. Crossref, MedlineGoogle Scholar
  • 53 Bleeker-RoversCP, Bredie SJ, van der Meer JW, Corstens FH, Oyen WJ. Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis. Am J Med2004; 116: 50–53. MedlineGoogle Scholar
  • 54 BlockmansD, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med2000; 108: 246–249. Crossref, MedlineGoogle Scholar
  • 55 MellerJ, Strutz F, Siefker U, et al. Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI. Eur J Nucl Med Mol Imaging2003; 30: 730–736. Crossref, MedlineGoogle Scholar

Article History

Published in print: Sept 2005